Cell-mediated immune responses induced by BHV-1: rational vaccine design (Q36837139)

16 August 2017

1 reference

title

Cell-mediated immune responses induced by BHV-1: rational vaccine design (English)

1 reference

Sylvia van Drunen Littel-van den Hurk

16 August 2017

1 reference

series ordinal

1

object named as

Sylvia van Drunen Littel-van den Hurk

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Expert Review of Vaccines

16 August 2017

published in

1 reference

16 August 2017

volume

6

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

369-380

1 reference

Pathogenesis of ruminant herpesvirus infections

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Herpes simplex virus type 1 and bovine herpesvirus 1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Pro and contra IBR-eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Molecular virology of ruminant herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

CD4 T cells are required for secondary expansion and memory in CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Lymphocyte proliferative responses to recombinant bovine herpes virus type 1 (BHV-1) glycoprotein gD (gIV) in immune cattle: identification of a T cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Human T Cells Recognize Multiple Epitopes of an Immediate Early/Tegument Protein (IE62) and Glycoprotein I of Varicella Zoster Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Effects of virion host shut-off activity of bovine herpesvirus 1 on MHC class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Bovine herpesvirus 1 interferes with TAP-dependent peptide transport and intracellular trafficking of MHC class I molecules in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Cell-mediated immunity and the challenges for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Translating innate immunity into immunological memory: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Immunoregulation in the tissues by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Adaptive immune response of Vγ2Vδ2 T cells: a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

T cell vaccines for microbial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Prominence of gamma delta T cells in the ruminant immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Antigen-specific in vitro activation of T-lymphocyte subsets of cattle immunized with a modified live bovine herpesvirus 1 vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Monitoring responses by use of five-color flow cytometry in subsets of peripheral T cells obtained from cattle inoculated with a killed Mycobacterium avium subsp paratuberculosis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Rationale and perspectives on the success of vaccination against bovine herpesvirus-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Diva vaccines that reduce virus transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Epitopes on glycoprotein E and on the glycoprotein E/glycoprotein I complex of bovine herpesvirus 1 are expressed by all of 222 isolates and 11 vaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Early immunity induced by a glycoprotein E-negative vaccine for infectious bovine rhinotracheitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Fetal immunization by a DNA vaccine delivered into the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Delivery of DNA vaccines by agarose hydrogel implants facilitates genetic immunization in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Therapeutic potential of Toll-like receptor 9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Prime-boost immunization generates a high frequency, high-avidity CD8( ) cytotoxic T lymphocyte population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Genetic immunization against anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

The impact of genomics on vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

From functional genomics to functional immunomics: new challenges, old problems, big rewards

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.369

21 January 2018

Identifiers

DOI

10.1586/14760584.6.3.369

1 reference

16 August 2017

1 reference